{
    "title": "Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).",
    "abst": "Galanthamine hydrobromide, an anticholinesterase drug capable of penetrating the blood-brain barrier, was used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage. It is longer acting than physostigmine and is used in anaesthesia to reverse the non-depolarizing neuromuscular block. However, studies into the dose necessary to combating scopolamine intoxication are indicated.",
    "title_plus_abst": "Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine). Galanthamine hydrobromide, an anticholinesterase drug capable of penetrating the blood-brain barrier, was used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage. It is longer acting than physostigmine and is used in anaesthesia to reverse the non-depolarizing neuromuscular block. However, studies into the dose necessary to combating scopolamine intoxication are indicated.",
    "pubmed_id": "603022",
    "entities": [
        [
            0,
            25,
            "Galanthamine hydrobromide",
            "Chemical",
            "D005702"
        ],
        [
            111,
            122,
            "scopolamine",
            "Chemical",
            "D012601"
        ],
        [
            124,
            132,
            "Hyoscine",
            "Chemical",
            "D012601"
        ],
        [
            135,
            160,
            "Galanthamine hydrobromide",
            "Chemical",
            "D005702"
        ],
        [
            292,
            303,
            "scopolamine",
            "Chemical",
            "D012601"
        ],
        [
            305,
            313,
            "hyoscine",
            "Chemical",
            "D012601"
        ],
        [
            315,
            325,
            "overdosage",
            "Disease",
            "D062787"
        ],
        [
            352,
            365,
            "physostigmine",
            "Chemical",
            "D010830"
        ],
        [
            500,
            511,
            "scopolamine",
            "Chemical",
            "D012601"
        ]
    ],
    "split_sentence": [
        "Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).",
        "Galanthamine hydrobromide, an anticholinesterase drug capable of penetrating the blood-brain barrier, was used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage.",
        "It is longer acting than physostigmine and is used in anaesthesia to reverse the non-depolarizing neuromuscular block.",
        "However, studies into the dose necessary to combating scopolamine intoxication are indicated."
    ],
    "if_txt_length_is_changed_flag": 0,
    "lines": [
        "D005702\tChemical\tGalanthamine hydrobromide\t<target> Galanthamine hydrobromide </target> , a longer acting anticholinesterase drug , in the treatment of the central effects of scopolamine ( Hyoscine ) .",
        "D012601\tChemical\tscopolamine\tGalanthamine hydrobromide , a longer acting anticholinesterase drug , in the treatment of the central effects of <target> scopolamine </target> ( Hyoscine ) .",
        "D012601\tChemical\tHyoscine\tGalanthamine hydrobromide , a longer acting anticholinesterase drug , in the treatment of the central effects of scopolamine ( <target> Hyoscine </target> ) .",
        "D005702\tChemical\tGalanthamine hydrobromide\t<target> Galanthamine hydrobromide </target> , an anticholinesterase drug capable of penetrating the blood-brain barrier , was used in a patient demonstrating central effects of scopolamine ( hyoscine ) overdosage .",
        "D012601\tChemical\tscopolamine\tGalanthamine hydrobromide , an anticholinesterase drug capable of penetrating the blood-brain barrier , was used in a patient demonstrating central effects of <target> scopolamine </target> ( hyoscine ) overdosage .",
        "D012601\tChemical\thyoscine\tGalanthamine hydrobromide , an anticholinesterase drug capable of penetrating the blood-brain barrier , was used in a patient demonstrating central effects of scopolamine ( <target> hyoscine </target> ) overdosage .",
        "D062787\tDisease\toverdosage\tGalanthamine hydrobromide , an anticholinesterase drug capable of penetrating the blood-brain barrier , was used in a patient demonstrating central effects of scopolamine ( hyoscine ) <target> overdosage </target> .",
        "D010830\tChemical\tphysostigmine\tIt is longer acting than <target> physostigmine </target> and is used in anaesthesia to reverse the non-depolarizing neuromuscular block .",
        "D012601\tChemical\tscopolamine\tHowever , studies into the dose necessary to combating <target> scopolamine </target> intoxication are indicated ."
    ],
    "lines_lemma": [
        "D005702\tChemical\tGalanthamine hydrobromide\t<target> Galanthamine hydrobromide </target> , a long acting anticholinesterase drug , in the treatment of the central effect of scopolamine ( hyoscine ) .",
        "D012601\tChemical\tscopolamine\tGalanthamine hydrobromide , a long acting anticholinesterase drug , in the treatment of the central effect of <target> scopolamine </target> ( hyoscine ) .",
        "D012601\tChemical\tHyoscine\tGalanthamine hydrobromide , a long acting anticholinesterase drug , in the treatment of the central effect of scopolamine ( <target> hyoscine </target> ) .",
        "D005702\tChemical\tGalanthamine hydrobromide\t<target> Galanthamine hydrobromide </target> , an anticholinesterase drug capable of penetrate the blood-brain barrier , be use in a patient demonstrate central effect of scopolamine ( hyoscine ) overdosage .",
        "D012601\tChemical\tscopolamine\tGalanthamine hydrobromide , an anticholinesterase drug capable of penetrate the blood-brain barrier , be use in a patient demonstrate central effect of <target> scopolamine </target> ( hyoscine ) overdosage .",
        "D012601\tChemical\thyoscine\tGalanthamine hydrobromide , an anticholinesterase drug capable of penetrate the blood-brain barrier , be use in a patient demonstrate central effect of scopolamine ( <target> hyoscine </target> ) overdosage .",
        "D062787\tDisease\toverdosage\tGalanthamine hydrobromide , an anticholinesterase drug capable of penetrate the blood-brain barrier , be use in a patient demonstrate central effect of scopolamine ( hyoscine ) <target> overdosage </target> .",
        "D010830\tChemical\tphysostigmine\tit be long act than <target> physostigmine </target> and be use in anaesthesia to reverse the non-depolarizing neuromuscular block .",
        "D012601\tChemical\tscopolamine\thowever , study into the dose necessary to combat <target> scopolamine </target> intoxication be indicate ."
    ]
}